295 related articles for article (PubMed ID: 26303144)
1. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
[TBL] [Abstract][Full Text] [Related]
2. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
[TBL] [Abstract][Full Text] [Related]
5. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological staging of spinocerebellar ataxia type 2 by semiquantitative 1C2-positive neuron typing. Nuclear translocation of cytoplasmic 1C2 underlies disease progression of spinocerebellar ataxia type 2.
Koyano S; Yagishita S; Kuroiwa Y; Tanaka F; Uchihara T
Brain Pathol; 2014 Nov; 24(6):599-606. PubMed ID: 24674145
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of exoribonucleases (DIS3L2 and XRN1) in intranuclear inclusion body disease.
Mori F; Tanji K; Miki Y; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2018 Jan; 662():389-394. PubMed ID: 29100804
[TBL] [Abstract][Full Text] [Related]
8. Polyglutamine disease: recent advances in the neuropathology of dentatorubral-pallidoluysian atrophy.
Yamada M; Shimohata M; Sato T; Tsuji S; Takahashi H
Neuropathology; 2006 Aug; 26(4):346-51. PubMed ID: 16961072
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.
Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF
Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
Mori F; Tanji K; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Kamitani T; Yoshida M; Wakabayashi K
Pathol Int; 2012 Jun; 62(6):407-11. PubMed ID: 22612509
[TBL] [Abstract][Full Text] [Related]
11. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
[TBL] [Abstract][Full Text] [Related]
12. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
Yamada M; Tan CF; Inenaga C; Tsuji S; Takahashi H
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):665-75. PubMed ID: 15541006
[TBL] [Abstract][Full Text] [Related]
13. [Polyglutamine diseases: a pathologic view].
Yamada M
Rinsho Shinkeigaku; 2003 Nov; 43(11):903-5. PubMed ID: 15152499
[TBL] [Abstract][Full Text] [Related]
14. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease.
Mori F; Tanji K; Kon T; Odagiri S; Hattori M; Hoshikawa Y; Kono C; Yasui K; Yokoi S; Hasegawa Y; Yoshida M; Wakabayashi K
Neuropathol Appl Neurobiol; 2012 Jun; 38(4):322-8. PubMed ID: 21883376
[TBL] [Abstract][Full Text] [Related]
15. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture.
Pountney DL; Raftery MJ; Chegini F; Blumbergs PC; Gai WP
Acta Neuropathol; 2008 Dec; 116(6):603-14. PubMed ID: 18836734
[TBL] [Abstract][Full Text] [Related]
16. Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Ikeda T; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2012 Jul; 124(1):149-51. PubMed ID: 22661321
[No Abstract] [Full Text] [Related]
17. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases.
de Pril R; Fischer DF; Roos RA; van Leeuwen FW
Mol Cell Neurosci; 2007 Jan; 34(1):10-9. PubMed ID: 17092742
[TBL] [Abstract][Full Text] [Related]
18. Pathology of CAG repeat diseases.
Yamada M; Tsuji S; Takahashi H
Neuropathology; 2000 Dec; 20(4):319-25. PubMed ID: 11211058
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases.
de Pril R; Fischer DF; Maat-Schieman ML; Hobo B; de Vos RA; Brunt ER; Hol EM; Roos RA; van Leeuwen FW
Hum Mol Genet; 2004 Aug; 13(16):1803-13. PubMed ID: 15198995
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal protein SA is a common component of neuronal intranuclear inclusions in polyglutamine diseases and Marinesco bodies.
Yagita K; Sadashima S; Koyama S; Noguchi H; Hamasaki H; Sasagasako N; Honda H
Neuropathology; 2024 Feb; 44(1):31-40. PubMed ID: 37340992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
